Stockreport

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

Cartesian Therapeutics, Inc.  (RNAC) 
PDF FREDERICK, Md., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA c [Read more]